Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,497 | 429 | 49.7% |
| Consulting Fee | $6,180 | 2 | 41.0% |
| Travel and Lodging | $1,385 | 5 | 9.2% |
| Education | $21.89 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $7,658 | 11 | $0 (2019) |
| Novo Nordisk Inc | $1,284 | 75 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,088 | 67 | $0 (2024) |
| Lilly USA, LLC | $925.24 | 56 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $880.86 | 51 | $0 (2024) |
| PFIZER INC. | $382.15 | 24 | $0 (2024) |
| Abbott Laboratories | $379.40 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $364.07 | 24 | $0 (2023) |
| ABBVIE INC. | $337.94 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $328.10 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $851.19 | 39 | Lilly USA, LLC ($297.69) |
| 2023 | $894.16 | 36 | Abbott Laboratories ($287.23) |
| 2022 | $838.63 | 37 | Novo Nordisk Inc ($166.43) |
| 2021 | $554.73 | 34 | Novo Nordisk Inc ($138.67) |
| 2020 | $532.87 | 35 | AstraZeneca Pharmaceuticals LP ($152.58) |
| 2019 | $8,624 | 76 | Eisai Inc. ($7,658) |
| 2018 | $1,356 | 90 | Novo Nordisk Inc ($320.48) |
| 2017 | $1,432 | 92 | AstraZeneca Pharmaceuticals LP ($314.62) |
All Payment Transactions
439 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardio-renal | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: VACCINE | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.90 | General |
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: VACCINES | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $98.52 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $48.84 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 07/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Obesity | ||||||
| 05/15/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Neuroscience | ||||||
| 04/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.71 | General |
| 04/11/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $19.76 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 241 | 383 | $70,084 | $23,208 |
| 2022 | 11 | 378 | 724 | $123,914 | $44,448 |
| 2021 | 15 | 848 | 1,304 | $156,297 | $55,698 |
| 2020 | 10 | 411 | 693 | $119,653 | $38,559 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 200 | $48,656 | $14,973 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $10,680 | $5,496 | 51.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 24 | $3,720 | $1,310 | 35.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 33 | 50 | $3,091 | $476.00 | 15.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 13 | 19 | $1,197 | $460.75 | 38.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 20 | 26 | $1,600 | $341.12 | 21.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 19 | $1,140 | $151.48 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 114 | 357 | $85,680 | $28,280 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 71 | 71 | $17,040 | $8,928 | 52.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 39 | $6,045 | $2,222 | 36.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 21 | $1,659 | $1,439 | 86.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 16 | 46 | $2,898 | $1,165 | 40.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 46 | 90 | $5,850 | $863.81 | 14.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 24 | $1,200 | $674.10 | 56.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $420.00 | $338.75 | 80.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 29 | 29 | $1,740 | $283.86 | 16.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 11 | 16 | $1,040 | $211.15 | 20.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 14 | 19 | $342.00 | $42.41 | 12.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 130 | 377 | $90,480 | $30,349 | 33.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 68 | 68 | $16,320 | $8,879 | 54.4% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 138 | 138 | $12,451 | $4,397 | 35.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 137 | 140 | $11,030 | $2,802 | 25.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 32 | 32 | $2,528 | $2,023 | 80.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 27 | $4,185 | $1,856 | 44.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 16 | 16 | $3,200 | $1,259 | 39.3% |
About Dr. Mohan Chilukuri, MD
Dr. Mohan Chilukuri, MD is a Family Medicine healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407951882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohan Chilukuri, MD has received a total of $15,084 in payments from pharmaceutical and medical device companies, with $851.19 received in 2024. These payments were reported across 439 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($7,497).
As a Medicare-enrolled provider, Chilukuri has provided services to 1,878 Medicare beneficiaries, totaling 3,104 services with total Medicare billing of $161,914. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Durham, NC
- Active Since 09/13/2006
- Last Updated 09/28/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1407951882
Products in Payments
- Ozempic (Drug) $615.00
- JARDIANCE (Drug) $614.64
- FARXIGA (Drug) $572.84
- MOUNJARO (Drug) $401.76
- FREESTYLE LIBRE 3 (Device) $287.23
- XARELTO (Drug) $236.98
- TRULICITY (Drug) $231.74
- Rybelsus (Drug) $198.98
- SYMBICORT (Drug) $180.27
- VRAYLAR (Drug) $175.15
- BEVESPI AEROSPHERE (Drug) $169.06
- STIOLTO RESPIMAT (Drug) $139.01
- SHINGRIX (Biological) $134.11
- ELIQUIS (Drug) $120.99
- PREVNAR - 13 (Biological) $118.20
- UBRELVY (Drug) $102.68
- PREVNAR 20 (Biological) $98.32
- FREESTYLE LIBRE 2 (Device) $92.17
- SOLIQUA (Drug) $91.14
- NURTEC ODT (Drug) $90.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Durham
Dr. Theodore Bruno, Md, MD
Family Medicine — Payments: $201,463
Margie Sander, M.d, M.D
Family Medicine — Payments: $62,637
Dr. Devdutta Sangvai, M.d, M.D
Family Medicine — Payments: $35,420
Linda Bissonnette, M.d, M.D
Family Medicine — Payments: $21,770
Dr. John Ragsdale, Md, MD
Family Medicine — Payments: $19,561
Dr. Lorraine Sease, Md, Msph, MD, MSPH
Family Medicine — Payments: $12,515